Showing 561 - 580 results of 8,186 for search '"neurodegeneration"', query time: 0.13s Refine Results
  1. 561

    Source space connectomics of neurodegeneration: One-metric approach does not fit all by Pavel Prado, Sebastian Moguilner, Jhony A. Mejía, Agustín Sainz-Ballesteros, Mónica Otero, Agustina Birba, Hernando Santamaria-Garcia, Agustina Legaz, Sol Fittipaldi, Josephine Cruzat, Enzo Tagliazucchi, Mario Parra, Rubén Herzog, Agustín Ibáñez

    Published 2023-04-01
    “…These joint analyses reveal patterns of brain functional interdependence that are overlooked with single metrics approaches, contributing to a more reliable and interpretable description of atypical functional connectivity in neurodegeneration.…”
    Get full text
    Article
  2. 562
  3. 563

    Nipecotic Acid Derivatives as Potent Agents against Neurodegeneration: A Preliminary Study by Georgios Papagiouvannis, Panagiotis Theodosis-Nobelos, Eleni A. Rekka

    Published 2022-10-01
    “…Acetylcholinesterase inhibitors are the main therapeutic agents against AD, whereas oxidative stress and inflammation have been found to be of great significance for the development and progression of neurodegeneration. In this work, ethyl nipecotate (ethyl-piperidine-3-carboxylate), a heterocyclic carboxylic acid derivative, which acts as a GABA reuptake inhibitor and has been used in research for diseases involving GABAergic neurotransmission dysfunction, was amidated with various carboxylic acids bearing antioxidant and/or anti-inflammatory properties (e.g., ferulic acid, sinapic acid, butylated hydroxycinnamic acid). …”
    Get full text
    Article
  4. 564
  5. 565
  6. 566

    Effects of Enteric Environmental Modification by Coffee Components on Neurodegeneration in Rotenone-Treated Mice by Ikuko Miyazaki, Nami Isooka, Kouichi Wada, Ryo Kikuoka, Yoshihisa Kitamura, Masato Asanuma

    Published 2019-03-01
    “…Administrations of CA or CGA prevented rotenone-induced neurodegeneration of both nigral dopaminergic and intestinal enteric neurons. …”
    Get full text
    Article
  7. 567
  8. 568

    Neurodegeneration Biomarkers in Adult Spinal Muscular Atrophy (SMA) Patients Treated with Nusinersen by Pol Andrés-Benito, Juan Francisco Vázquez-Costa, Nancy Carolina Ñungo Garzón, María J. Colomina, Carla Marco, Laura González, Cristina Terrafeta, Raúl Domínguez, Isidro Ferrer, Mónica Povedano

    Published 2024-03-01
    “…A reduction in sAPPβ levels was found after nusinersen treatment, but these levels did not correlate with clinical outcomes. Other neurodegeneration biomarkers (NF-L, pNF-H, total tau, YKL-40, Aβ40, and Aβ42) were not found consistently changed with nusinersen treatment. …”
    Get full text
    Article
  9. 569

    Transcript Variants of Genes Involved in Neurodegeneration Are Differentially Regulated by the APOE and MAPT Haplotypes by Sulev Koks, Abigail L. Pfaff, Vivien J. Bubb, John P. Quinn

    Published 2021-03-01
    “…APOE e4 and MAPT H1/H2 haplotypic variants are associated with the expression of several genes related to the neurodegeneration.…”
    Get full text
    Article
  10. 570
  11. 571
  12. 572
  13. 573
  14. 574
  15. 575

    Mitochondrial Dysfunction, Oxidative Stress and Neuroinflammation in Neurodegeneration with Brain Iron Accumulation (NBIA) by Isabel Hinarejos, Candela Machuca, Paula Sancho, Carmen Espinós

    Published 2020-10-01
    “…The syndromes of neurodegeneration with brain iron accumulation (NBIA) encompass a group of invalidating and progressive rare diseases that share the abnormal accumulation of iron in the basal ganglia. …”
    Get full text
    Article
  16. 576
  17. 577
  18. 578
  19. 579
  20. 580